IMNN logo

Imunon (IMNN) Company Overview

Profile

Full Name:

Imunon, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 1, 1999

Indexes:

Not included

Description:

IMNN, or Imunon, is a biotechnology company focused on developing innovative therapies for cancer and infectious diseases. They use advanced technologies to create treatments that boost the immune system, aiming to improve patient outcomes and quality of life. Their research targets both existing and new medical challenges.

Events Calendar

Earnings

Next earnings date:

May 13, 2025

Recent quarterly earnings:

Feb 27, 2025

Recent annual earnings:

Feb 27, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 1, 2022

Analyst ratings

Recent major analysts updates

Feb 27, 25 D. Boral Capital
Buy
Feb 19, 25 D. Boral Capital
Buy
Jan 24, 25 D. Boral Capital
Buy
Dec 19, 24 HC Wainwright & Co.
Buy
Dec 19, 24 D. Boral Capital
Buy
Dec 11, 24 HC Wainwright & Co.
Buy
Dec 10, 24 D. Boral Capital
Buy
Nov 25, 24 D. Boral Capital
Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Nov 7, 24 EF Hutton
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Imunon?
  • Does Imunon pay dividends?
  • What sector is Imunon in?
  • What industry is Imunon in?
  • What country is Imunon based in?
  • When did Imunon go public?
  • Is Imunon in the S&P 500?
  • Is Imunon in the NASDAQ 100?
  • Is Imunon in the Dow Jones?
  • When was Imunon's last earnings report?
  • When does Imunon report earnings?
  • Should I buy Imunon stock now?

What is the ticker symbol for Imunon?

The ticker symbol for Imunon is NASDAQ:IMNN

Does Imunon pay dividends?

No, Imunon does not pay dividends

What sector is Imunon in?

Imunon is in the Healthcare sector

What industry is Imunon in?

Imunon is in the Biotechnology industry

What country is Imunon based in?

Imunon is headquartered in United States

When did Imunon go public?

Imunon's initial public offering (IPO) was on March 1, 1999

Is Imunon in the S&P 500?

No, Imunon is not included in the S&P 500 index

Is Imunon in the NASDAQ 100?

No, Imunon is not included in the NASDAQ 100 index

Is Imunon in the Dow Jones?

No, Imunon is not included in the Dow Jones index

When was Imunon's last earnings report?

Imunon's most recent earnings report was on Feb 27, 2025

When does Imunon report earnings?

The next expected earnings date for Imunon is May 13, 2025

Should I buy Imunon stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions